2020-25019. Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.
Start SignatureTable 1—List of Information Collections Approved by OMB
Title of collection OMB control No. Date approval expires Required Warnings for Cigarette Packages and Advertisements 0910-0877 04/30/2023 Medical Devices; Reports of Corrections and Removals 0910-0359 10/31/2023 Customer/Partner Service Surveys 0910-0360 10/31/2023 Annual Reporting for Custom Device Exemption 0910-0767 10/31/2023 Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act 0910-0800 10/31/2023 Postmarketing Safety Reporting for Combination Products 0910-0834 10/31/2023 Importation of Prescription Drugs 0910-0888 10/31/2023 Start Printed Page 71923End Signature End Supplemental InformationDated: November 5, 2020.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2020-25019 Filed 11-10-20; 8:45 am]
BILLING CODE 4164-01-P
Document Information
- Published:
- 11/12/2020
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice.
- Document Number:
- 2020-25019
- Pages:
- 71922-71923 (2 pages)
- Docket Numbers:
- Docket Nos. FDA-2019-N-3065, FDA-2016-N-4620, FDA-2019-N-6063, FDA-2017-N-1066, FDA-2018-N-3065, FDA-2008-N-0424, and FDA-2019-N-5711
- PDF File:
- 2020-25019.pdf
- Supporting Documents:
- » Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
- » Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act
- » Final Standard MOU Addressing Certain Distributions of Compounded Human Drug Products - Not For Implementation
- » Request for Extension from International Academy of Compounding Pharmacists (IACP)
- » Memorandum of Understanding Addressing Certain Distributions of Compounded Drug Products Between the States and the Food and Drug Administration; Revised Draft; Availability